Lockwood C M, Worlledge S, Nicholas A, Cotton C, Peters D K
N Engl J Med. 1979 Mar 8;300(10):524-30. doi: 10.1056/NEJM197903083001003.
By studying the clearance of autologous labeled antibody-coated or heat-damaged erythrocytes, we showed that reversible blockade of the splenic component of reticuloendothelial function existed in 14 of 15 patients referred for treatment of nephritis or vasculitis. In 10 patients treated by plasma exchange--alone in three and combined with steroids and cytotoxic drugs in six--reversal of splenic blockade followed in nine, and in the three patients treated solely by plasma exchange this reversal was demonstrated to occur within 48 hours of the procedure. Only gradual reversal of splenic blockade was found in three of five patients treated by steroids with or without cytotoxic drugs; no change in splenic function was observed in two. When circulating immune complexes were detected by a C1q-binding assay, there was, in serial studies, an approximate inverse correlation between splenic function and the level of C1q-binding material, though hyposplenism was also a feature of patients in whom the C1q-binding assay was negative.
通过研究自体标记的抗体包被或热损伤红细胞的清除情况,我们发现,在15例因肾炎或血管炎前来治疗的患者中,有14例存在网状内皮功能的脾脏成分的可逆性阻断。在10例接受血浆置换治疗的患者中(3例单独接受血浆置换,6例联合使用类固醇和细胞毒性药物),9例患者的脾脏阻断得到逆转,在仅接受血浆置换治疗的3例患者中,这种逆转在治疗后48小时内得到证实。在5例接受类固醇治疗(无论是否联合细胞毒性药物)的患者中,只有3例患者的脾脏阻断逐渐逆转;2例患者的脾脏功能未观察到变化。当通过C1q结合试验检测循环免疫复合物时,在系列研究中,脾脏功能与C1q结合物质水平之间大致呈负相关,尽管脾功能减退也是C1q结合试验阴性患者的一个特征。